Mononit 60 Retard (Isosorbide Mononitrate)

Isosorbide mononitrate is converted in the body to nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting rise in cyclic GMP relaxes arteries and veins, lowering preload and afterload, decreasing myocardial oxygen demand, and increasing coronary blood flow to relieve ischemic chest pain.

The appropriate dose of Mononit 60 Retard is determined by the prescribing clinician based on the individual patient's condition, response, and tolerability. Physicians typically start with a low dose and may adjust it according to therapeutic goals and any side‑effects, but specific dosing regimens should not be assumed.

Safety data for isosorbide mononitrate in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers usually advise against routine use during pregnancy or breastfeeding unless absolutely necessary.

To order Mononit 60 Retard, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mononit 60 Retard belongs to the nitrate class, which primarily reduces cardiac workload through vasodilation. Compared with beta‑blockers or calcium‑channel blockers, nitrates act more directly on vascular smooth muscle and are often used when other agents are insufficient or contraindicated. Each class has a distinct side‑effect profile, so choice depends on patient‑specific factors.

Mononit 60 Retard tablets should be stored at ambient temperature below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain tablet integrity throughout its shelf life.

Mononit 60 Retard is taken orally as an extended‑release tablet. The tablet should be swallowed whole with a glass of water and not chewed, crushed, or broken, as altering the tablet can affect the controlled‑release mechanism and increase the risk of side effects.

The most serious risks include severe hypotension, which can lead to fainting or shock, and rare allergic reactions that may cause rash, swelling, or breathing difficulties. Patients should seek immediate medical attention if they experience sudden drops in blood pressure, chest pain, or signs of an allergic response.

Mononit 60 Retard is contraindicated in patients with known hypersensitivity to isosorbide mononitrate or other nitrates, those taking phosphodiesterase‑5 inhibitors (e.g., sildenafil) due to the risk of profound hypotension, and individuals with severe hypotension or cardiogenic shock. Clinicians should review a patient’s medication list and medical history before prescribing.